Core Viewpoint - Southern First (SFST) reported quarterly earnings of $0.81 per share, exceeding the Zacks Consensus Estimate of $0.65 per share, and showing significant growth from $0.37 per share a year ago, indicating strong financial performance [1][2] Financial Performance - The company achieved revenues of $28.63 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 7.81%, compared to $23.05 million in the same quarter last year [2] - Southern First has consistently outperformed consensus EPS estimates over the last four quarters, achieving earnings surprises of +24.62% in the latest quarter and +6.56% in the previous quarter [1][2] Stock Performance and Outlook - Southern First shares have increased by approximately 0.9% since the beginning of the year, underperforming compared to the S&P 500's gain of 7.2% [3] - The company's current Zacks Rank is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is $0.73 on revenues of $27.89 million, and for the current fiscal year, it is $2.79 on revenues of $108.88 million [7] - The trend of earnings estimate revisions is mixed ahead of the earnings release, which may influence future stock performance [6] Industry Context - The Banks - Southeast industry, to which Southern First belongs, is currently ranked in the top 16% of over 250 Zacks industries, suggesting a favorable environment for performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact investor sentiment [5]

Over the last four quarters, the company has surpassed consensus EPS estimates three times. Avery Dennison, which belongs to the Zacks Containers - Paper and Packaging industry, posted revenues of $2.22 billion for the quarter ended June 2025, missing the Zacks Consensus Estimate by 0.5%. This compares to year-ago revenues of $2.24 billion. The company has not been able to beat consensus revenue estimates over the last four quarters. The sustainability of the stock's immediate price movement based on the re ...

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Danaher shares have lost about 18.1% since the beginning of the year versus the S&P 500's gain of 7.2%. Danaher (DHR) came out with quarterly earnings of $1.8 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.72 per share a year ago. These figures are adjusted fo ...

Company Performance - Medpace reported quarterly earnings of $3.1 per share, exceeding the Zacks Consensus Estimate of $3 per share, and up from $2.75 per share a year ago, representing an earnings surprise of +3.33% [1] - The company posted revenues of $603.31 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 11.48%, compared to year-ago revenues of $528.1 million [2] - Over the last four quarters, Medpace has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Performance and Outlook - Medpace shares have declined approximately 6.1% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The company's earnings outlook will be crucial for future stock performance, with current consensus EPS estimates at $2.95 for the coming quarter and $12.68 for the current fiscal year [4][7] - The estimate revisions trend for Medpace was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical Services industry, to which Medpace belongs, is currently in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - The performance of Medpace's stock may also be influenced by the overall industry outlook, as empirical research indicates a strong correlation between near-term stock movements and earnings estimate revisions [5][8]

Group 1 - Crown Holdings reported quarterly earnings of $2.15 per share, exceeding the Zacks Consensus Estimate of $1.86 per share, and up from $1.81 per share a year ago, representing an earnings surprise of +15.59% [1] - The company posted revenues of $3.15 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.39%, and an increase from $3.04 billion year-over-year [2] - Crown has outperformed the S&P 500 with a stock price increase of about 28.5% since the beginning of the year, compared to the S&P 500's gain of 7.1% [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is $1.98 on revenues of $3.16 billion, and for the current fiscal year, it is $7.11 on revenues of $12.16 billion [7] - The Containers - Metal and Glass industry, to which Crown belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable outlook [8] Group 3 - The estimate revisions trend for Crown was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Group 1 - Verizon Communications reported quarterly earnings of $1.22 per share, exceeding the Zacks Consensus Estimate of $1.18 per share, and up from $1.15 per share a year ago, representing an earnings surprise of +3.39% [1] - The company posted revenues of $34.5 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.76%, compared to year-ago revenues of $32.8 billion [2] - Over the last four quarters, Verizon has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Group 2 - The stock's immediate price movement will depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] - Verizon shares have increased about 2.1% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The current consensus EPS estimate for the coming quarter is $1.20 on revenues of $33.88 billion, and for the current fiscal year, it is $4.68 on revenues of $137.15 billion [7] Group 3 - The Zacks Industry Rank indicates that the Wireless National industry is currently in the bottom 27% of over 250 Zacks industries, which may impact Verizon's stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for Verizon was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it will perform in line with the market in the near future [6]

Core Insights - Badger Meter, Inc. (BMI) is positioned favorably for an upcoming earnings report, with positive trends indicating a potential earnings beat [1][5] Earnings Estimates - Recent earnings estimate revisions for BMI have been favorable, suggesting analysts are optimistic about the company's performance [2] - The Most Accurate Estimate for the upcoming quarter is $1.28 per share, compared to the broader Zacks Consensus Estimate of $1.21 per share, indicating a recent upward revision by analysts [3] Earnings ESP - BMI has a Zacks Earnings ESP of +5.61%, which is a positive indicator heading into earnings season [3] - A positive Zacks Earnings ESP has historically led to positive surprises and outperformance in the market, with a nearly 70% success rate in producing positive surprises [4] Investment Consideration - With a Zacks Rank of 3 (Hold) and a positive Earnings ESP, BMI may be a stock worth considering for investors ahead of the earnings report [5]

Core Viewpoint - Fiserv (FI) shares have increased by 1.4% over the past month, closing at $165.74, with a potential upside of 31.6% based on Wall Street analysts' mean price target of $218.09 [1] Group 1: Price Targets and Analyst Estimates - The mean estimate consists of 34 short-term price targets with a standard deviation of $31.63, indicating variability among analysts; the lowest estimate is $125.00 (24.6% decline), while the highest is $268.00 (61.7% increase) [2] - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual stock price movements [7] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price direction, serving as a starting point for further research [9] Group 2: Earnings Estimates and Market Sentiment - There is growing optimism among analysts regarding Fiserv's earnings prospects, supported by a consensus of higher EPS estimates, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 0.2%, with four estimates moving higher and no negative revisions [12] - Fiserv holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13]

Group 1 - Cleveland-Cliffs reported a quarterly loss of $0.5 per share, better than the Zacks Consensus Estimate of a loss of $0.68, and compared to earnings of $0.11 per share a year ago, representing an earnings surprise of +26.47% [1] - The company posted revenues of $4.93 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.62%, but down from $5.09 billion year-over-year [2] - Cleveland-Cliffs shares have increased approximately 0.9% since the beginning of the year, while the S&P 500 has gained 7.1% [3] Group 2 - The earnings outlook for Cleveland-Cliffs is mixed, with the current consensus EPS estimate for the coming quarter at -$0.20 on revenues of $4.97 billion, and -$1.69 on revenues of $19.46 billion for the current fiscal year [7] - The Zacks Industry Rank indicates that the Steel - Producers industry is currently in the bottom 14% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] Group 3 - Cleveland-Cliffs has surpassed consensus EPS estimates only once in the last four quarters, while it has topped consensus revenue estimates three times during the same period [2][6] - The estimate revisions trend for Cleveland-Cliffs was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]

Group 1 - Enliven Therapeutics, Inc. (ELVN) shares have increased by 8.2% over the past four weeks, closing at $23.34, with a mean price target of $41 indicating a potential upside of 75.7% [1] - The mean estimate consists of eight short-term price targets with a standard deviation of $6.74, where the lowest estimate of $33.00 suggests a 41.4% increase, and the highest estimate of $52.00 indicates a potential surge of 122.8% [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases, as the Zacks Consensus Estimate for the current year has risen by 4.6% over the past month [11][12] Group 2 - ELVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential for upside [13] - While consensus price targets may not be reliable indicators of the extent of gains, they can provide a directional guide for price movement [14]